Explore more publications!

The New Jersey Post: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on The New Jersey Post.

Press releases published on November 13, 2025

GOOSE HOLLOW CAPITAL MANAGEMENT ANNOUNCES AN ETF CLOSURE
A Guide to Fall Prevention Tips for Seniors Living in Cherry Hill Homes
Peace Care St. Ann’s and St. Joseph’s Named Among 2026 Best Nursing Homes in New Jersey by U.S. News
The Physicians of Coastal Spine Have Been Awarded As 2025 NJ Top Docs
NJ Top Docs Has Reviewed & Approved 11 Medicor Cardiology Physicians
Oncology Data Advisor® Welcomes Matthew Hadfield, DO, as Editor in Chief
Private Biotech Summit Strengthens Korea–U.S. Pathways in Trials and AI Platforms
Felicia Bechtel Recognized by Influential Women as a Transformative Force in Home Organization
Gorlin Pools Launches ‘Season of Gratitude’ Campaign to Give Back to Local Charity
Bio Green Med Solution Reports Third Quarter Financial Results and Provides Business Update
Aterian Reports 2025 Third Quarter Financial Results and Reiterates Guidance
Amneal Receives U.S. FDA Approval for Iohexol Injection
Milestone Scientific Delivers Stable Revenue and Reduces Operating Expenses by Over $500 Thousand in the Third Quarter of 2025
Milestone Scientific Schedules Third Quarter 2025 Financial Results and Business Update Conference Call
High School Students Invited to Showcase Musical Talent in 2026 Your Song! Your Voice! Shout Down Drugs Competition
Ramsey Theory Group CEO Dan Herbatschek Announces New Enhancements to Its AI-Driven Healthcare Delivery System Erdos Medical and Increased Adoption in Los Angeles
Legend Biotech Celebrates Official Opening of New State-of-the-Art Cell Therapy Research and Development Facility in Philadelphia
Molded Pulp Packaging Market is expected to generate a revenue of USD 5.78 Billion by 2031, Globally, at 4.80% CAGR: Verified Market Research®
Verizon Business Powers Next-Generation Broadcasts for Monumental Sports & Entertainment
Outlook Therapeutics Announces Acceptance of Biologics License Application by U.S. FDA for ONS-5010 as a Treatment for Wet AMD

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms & Conditions